Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008



    QUEBEC CITY, Feb. 28 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:   AEZS,
TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and
oncology, will announce its fourth quarter and full-year 2007 financial and
operating results before market open on Wednesday, March 5, 2008. The Company
will host a conference call and webcast to discuss these results later that
same day at 10:00 a.m., Eastern Time.
    Participants may access the live webcast via the Company's website at
www.aezsinc.com in the "Investors" section, or by telephone using the
following numbers: 416-644-3425, 514-807-8791 or 800-595-8550. A replay of the
webcast will also be available on the Company's website for a period of
30 days.

    About Aeterna Zentaris Inc.

    Aeterna Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at www.aezsinc.com.




For further information:

For further information: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 626-5509, jthomas@aezsinc.com;
Paul Burroughs, Media Relations, (418) 652-8525 ext. 406,
pburroughs@aezsinc.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890